CancerIQ | About Us

The Problem

Cancer is being diagnosed at earlier ages and later stages

"Sarah" provides her family history at intake, generating a follow-up letter stating her lifetime breast cancer risk: >20% — a number that appears low. The Tyrer-Cuzick model recommends ordering a breast MRI.

Without genetic testing, the BRCA mutation that Sarah carried was never discovered, meaning she faced a significantly higher hereditary risk of a breast cancer diagnosis than the average woman.

The patient is diagnosed with late-stage breast cancer, leaving her asking a simple but difficult question: “Why didn’t anyone catch this sooner?”

Hear CancerIQ Co-Founder and CEO Feyi Olopade Ayodele unpack how a one-size-fits-all approach to cancer care fails to meet the needs of the 1 in 10 patients with the highest risk of a cancer diagnosis.

The Challenge

Most healthcare providers take a one-size-fits-all approach to breast care. This is bad for patient care — and it is bad for business.

More than 257,000 new cases of breast cancer are diagnosed in the United States annually; as many as 10% due to genetic or familial risk factors that can be addressed in advance.